Related references
Note: Only part of the references are listed.Baricitinib in Patients with Refractory Rheumatoid Arthritis
Mark C. Genovese et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Corticosteroid-Free Primary Treatment of Chronic Extensive Graft-versus-Host Disease Incorporating Rituximab
Scott R. Solomon et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
Measuring Therapeutic Response in Chronic Graft-versus-Host Disease. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2014 Response Criteria Working Group Report
Stephanie J. Lee et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
Madan H. Jagasia et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey
R. Zeiser et al.
LEUKEMIA (2015)
Current issues in chronic graft-versus-host disease
Gerard Socie et al.
BLOOD (2014)
Pharmacologic Blockade of JAK1/JAK2 Reduces GvHD and Preserves the Graft-Versus-Leukemia Effect
Jaebok Choi et al.
PLOS ONE (2014)
Extracorporeal photopheresis for chronic graft-versus-host disease: a systematic review and meta-analysis
Mohsin Ilyas Malik et al.
BLOOD RESEARCH (2014)
IFNγR signaling mediates alloreactive T-cell trafficking and GVHD
Jaebok Choi et al.
BLOOD (2012)
Consensus Conference on Clinical Practice in Chronic GVHD: Second-Line Treatment of Chronic Graft-versus-Host Disease
Daniel Wolff et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2011)
Global and organ-specific chronic graft-versus-host disease severity according to the 2005 NIH Consensus Criteria
Sally Arai et al.
BLOOD (2011)
Share Paper
